US 10081811
Organic compositions to treat Beta-ENaC-related diseases
granted A61KA61K31/713A61P
Quick answer
US patent 10081811 (Organic compositions to treat Beta-ENaC-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/713, A61P, A61P1/00, A61P1/18